Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

NCT02644044 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS

Interventions

DRUG: Intrathecal methotrexate

Sponsor

Tel-Aviv Sourasky Medical Center